Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Monetizing Science: Turning an Asset into Value through IPOs

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11548991
archived

This panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision making on prioritization within portfolios. 

Panelists include:

  • David Epstein, Flagship Pioneering
  • Dan Passeri, Cue Biopharma

Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Comments